Minerva Neurosciences NERV
NASDAQ NERV
$2.56 +0.07 (+2.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Minerva Neurosciences (NERV) Other Accumulated Expenses (2014 - 2017)

Updated

Minerva Neurosciences' Other Accumulated Expenses was $1.08 million in Q2 2015, down 26.2% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Other Accumulated Expenses (2014 - 2017) Analysis & Trends

At the end of FY2014, Other Accumulated Expenses at Minerva Neurosciences came in at $1.22 million.

  • Per Business Quant data, NERV's Other Accumulated Expenses in the three quarters before Q2 2015 was $1.46 million (Q1 2015), $1.22 million (Q4 2014) and $1.39 million (Q3 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Minerva Neurosciences 124.09 Mn -188.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 6.65 Mn
Mar 31, 2017 3.08 Mn
Dec 31, 2016 2.55 Mn
Sep 30, 2016 3.53 Mn
Jun 30, 2015 1.08 Mn
Mar 31, 2015 1.46 Mn
Dec 31, 2014 1.22 Mn
Sep 30, 2014 1.39 Mn
API Access

Minerva Neurosciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NERV&period=max&api_key=YOUR_API_KEY